Massachusetts S1478 aims to reduce allergic reaction risks by allowing businesses to provide epinephrine auto-injectors.
Massachusetts S1478 seeks to reduce the risks associated with allergic reactions by enabling businesses to provide epinephrine auto-injectors. The bill allows businesses to possess and make available epinephrine auto-injectors for immediate self-administration to individuals believed to be experiencing anaphylaxis. It mandates the Department of Public Health to develop regulations for the storage, administration, and training related to these devices.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.